Search

everythinglearnresearchcommunity

for

Search:↓

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

Methotrexate can temporarily suppress certain immune responses without killing immune cells, potentially helping treat autoimmune diseases.

Stem cell activity influences autoimmune disease outcomes by affecting immune responses and tissue regeneration.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

Controlling immune responses with biomaterials can reduce scarring and improve skin regeneration.

The article concludes that proper injection techniques and patient education can prevent serious skin reactions from multiple sclerosis medications.

Myeloid-derived suppressor cells help control autoimmune cells and promote hair regrowth in alopecia areata.

Enhancing glycolysis in mesenchymal stromal/stem cells boosts their immune functions and therapy potential.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Skin side effects from melanoma immunotherapy are common and may indicate better survival.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

IL-19 and IL-24 help cells respond to DNA damage and could be targeted for cancer and age-related disease treatments.

New treatments for alopecia areata show promise in improving hair loss outcomes.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

Upadacitinib improved multiple immune-related conditions in one patient.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Targeted immune modulation can help achieve stable remission in alopecia areata.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

Combining cytostatic and steroid drugs effectively treats systemic lupus erythematosus.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

AS101 reduces hair loss from chemotherapy.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.